Acuta Capital Partners’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Acuta Capital Partners’s Portfolio RAIN Stock Details RAIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-182,500	Closed	-$2.73M	–	56
2021 Q3	$2.73M	Buy	182,500 +20,255	+12%	+$345K	0.96%	27
2021 Q2	$2.52M	Buy	+162,245	New	+$2.84M	1.01%	31

Other funds holding RAIN

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Acuta Capital Partners's RAIN Position: Q4 2021 in Review

Acuta Capital Partners sold out of Rain Oncology Inc. Common Stock (RAIN) in Q4 2021, closing a stake of 182,500 shares — an estimated $2.73M sold.

Acuta Capital Partners first reported a position in RAIN in Q2 2021 and held it in 2 quarters. The position peaked at $2.73M in Q3 2021. 41 funds tracked by Wall St. Rank hold RAIN as of Q4 2021.

Acuta Capital Partners reported no remaining Rain Oncology Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Acuta Capital Partners sold 182,500 Rain Oncology Inc. Common Stock shares in Q4 2021, an estimated $2.73M.
Acuta Capital Partners first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 2 quarters.
Acuta Capital Partners's Rain Oncology Inc. Common Stock position peaked at $2.73M in Q3 2021.
41 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q4 2021.

Based on Acuta Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.